Literature DB >> 22911189

Amelanocytic anhidrotic alopecia areata-like phenotype after allogeneic hematopoietic cell transplant.

Edidong Celestine Ntuen Kamińska1, Richard A Larson, Vesna Petronic-Rosic.   

Abstract

BACKGROUND: Diffuse alopecia areata or canities subita is a rare variant of alopecia in which hair loss is associated with regrowth of white hairs and possible lightening of the skin. Preferential loss of pigmented hair in this disorder may be related to the melanin pigment system and/or melanocytes. Acquired generalized anhidrosis can be associated with autoimmune disease, cancer, graft-vs-host disease, or medications or can be idiopathic. Extensive anhidrosis may cause hyperpyrexia on exposure to heat, and protection from overheating is essential. OBSERVATIONS: A 38-year-old man with idiopathic autoimmune aplastic anemia developed permanent diffuse skin and hair whitening and generalized anhidrosis after a successful allogeneic hematopoietic stem cell transplant. Results of a histopathologic examination, which has previously not been reported in this disease, demonstrated a complete lack of epidermal and follicular melanocytes and a dense perifollicular and periadnexal lymphocytic infiltrate.
CONCLUSIONS: The hair- and skin-lightening phenomena in diffuse alopecia areata may be the result of an overstimulated immune system that targets epidermal and follicular melanocytes. Destruction results in irreversible pigmentary loss of the skin. In a patient with multiple risk factors for anhidrosis, a specific cause may be difficult to determine.

Entities:  

Mesh:

Year:  2012        PMID: 22911189     DOI: 10.1001/archdermatol.2012.335

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  2 in total

Review 1.  Vitiligo following stem-cell transplant.

Authors:  Alessio Totani; Hossam Amin; Stephen Bacchi; Ian Lewis
Journal:  Bone Marrow Transplant       Date:  2019-07-29       Impact factor: 5.483

2.  Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease.

Authors:  Rena C Zuo; Haley B Naik; Seth M Steinberg; Kristin Baird; Sandra A Mitchell; Zoya Kuzmina; Steven Z Pavletic; Edward W Cowen
Journal:  JAMA Dermatol       Date:  2015-01       Impact factor: 10.282

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.